Title

Treatment of Mucopolysaccharidosis Type II (Hunter syndrome)

Authoring Organization

Publication Month/Year

August 3, 2020

Last Updated Month/Year

February 6, 2024

Document Type

Consensus

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Female, Male, Adolescent, Child, Infant

Health Care Settings

Ambulatory

Intended Users

Medical techologist technician, genetics, nurse, nurse practitioner, physician, physician assistant

Scope

Management, Treatment

Diseases/Conditions (MeSH)

D016532 - Mucopolysaccharidosis II

Keywords

hunter syndrome, mucopolysaccharidosis, lysosomal storage disease, MPS II

Source Citation

McBride KL, Berry SA, Braverman N; ACMG Therapeutics Committee. Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020 Nov;22(11):1735-1742. doi: 10.1038/s41436-020-0909-z. Epub 2020 Aug 3. PMID: 32741966.

Supplemental Methodology Resources

Data Supplement